Navigation Links
Blackberries, Broccoli Sprouts Battle Cancer
Date:12/6/2007

chemical markers of oxidative stress in both urine and tissue samples.

Black raspberries previously have been shown to reduce the risk of oral, esophageal and colon cancer in animal models, according to the researchers, who called for further study in humans.

Dietitian Wendy Demark-Wahnefried, a professor of behavioral science at M.D. Anderson Cancer Center at the University of Texas in Houston, said she would feel comfortable advising people with Barrett's to eat black raspberries. "It couldn't hurt," she said, but added that further studies need to find out if the berries really do prevent cancer.

In other research presented at the meeting, broccoli sprouts and cruciferous vegetables both showed promise in the fight against bladder cancer, according to two separate teams from the Roswell Park Cancer Institute in Buffalo, N.Y.

Using a rat model, a team lead by Dr. Yuesheng Zhang, a professor of oncology, demonstrated that a broccoli sprout extract reduced bladder cancer in rats by 70 percent.

"Our present study shows that broccoli sprout extracts fed to rats in the diet inhibits bladder cancer development induced by a carcinogen. We don't yet know if the extracts inhibit the growth of a existing bladder cancer," said Zhang, who explained that broccoli sprouts are a rich source of a well-known cancer preventive agent known as sulforaphane.

"We next plan to find out if broccoli sprout extracts can fight bladder cancer in humans," Zhang noted.

A second team at the institute found that people who ate three or more servings of raw, cruciferous vegetables per month reduced their risk of bladder cancer by 40 percent. Cruciferous vegetables include broccoli, cabbage and cauliflower.

The team analyzed the dietary habits of 275 people with early bladder cancer and 825 people who were cancer-free. The researchers specifically asked how many servings of raw or cooked cruciferous vegetables they at
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Broccoli sprout-derived extract protects against ultraviolet radiation
2. Broccoli May Help Fight Skin Cancer
3. Battle Continues Over Vietnam PTSD Numbers
4. Life-Saving News for Battlefield Soldiers & Wounded Civilians
5. The Fight for His Life: Author, Family Battle Disease and Challenge Politics in the Face of Survival
6. National Battle of the Hospital Chefs Cooks Up a Winner
7. Parents can Help Young Superheroes Battle Cavities on Halloween Night
8. Early predictive model may be new weapon against leading cause of death on battlefield
9. Eyeglasses Upgrade Helps Elderly Battle Depression
10. Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis
11. World class technology and talent battle cancer at the Centenary Institute
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blackberries, Broccoli Sprouts Battle Cancer
Blackberries, Broccoli Sprouts Battle Cancer
(Date:7/23/2008)... Dr. Stephen Cohen Hired As New CEO, ATLANTA,...r Group,(GMCG) announced today that MELCO Investme...ment fund, has signed on as a key partner with a,s...the investment, GMCG has,also appointed Dr. Stephe...,surgeons, as its new CEO., (Photo: http://www.n...
(Date:7/23/2008)...d and Medicare Rules Highlighted; a Focus on Preve...tions, LANSING, Mich., July 23 /PRNewswire/ -- Th...&PSI), a national leader in clinical risk manageme... care institutions and,providers, today announced ... conference., The conference will take place Sept...
(Date:7/23/2008)... Michigan Takes Top Honors as the #1 Healthiest Ci...PRNewswire-USNewswire/ -- AARP The Magazine, the,d...largest-circulation,magazine with more than 34 mil...st cities to live and retire in with Ann Arbor, MI...go, ND taking the top five rankings.,Featured in t...
(Date:7/23/2008)...a., July 23 /PRNewswire-USNewswire/ -- The HealthC...m ) today announced that Dr. Fran Cogen,MD, direc...am at Children,s,National Medical Center, will pro...om, a site offering connections to a community of ...priate consultation by a dietician, social,worker,...
Breaking Medicine News(10 mins):Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 2Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 3Health News:The Risk Management and Patient Safety Institute Announces 2008/2009 Annual Risk Management Conference, Dates 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 3Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 4Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 5Health News:Children's National Medical Center Program Director to Provide Expertise to DiabeTeens.com, The HealthCentral Network's Teen Diabetes Site 2
...n often disabling condition that affects primarily...ted fatigue // that cannot be overcome with rest a... of the condition is unknown, and there are no dia...hat children who have sedentary behaviors are at i...
...n between the use of two of the most common medica... risk for // bone fractures. Beta-blockers are com...e heart failure, chest pain, and abnormal heart rh...e drugs to prevent a second attack. Diuretics are ...
...Wake Forest University Baptist Medical Center rese...r research in monkeys suggested //that the type of...t heart attack severity. At an annual meeting of...in Washington, D.C. today, Dr. J. Koudy Williams w...
...essive eye disease targeting the light-collecting ...orldwide and can cause // vision loss. Researchers...osa, the addition of docosahexaenoic acid to vitam...enefits, according to a recent study. Researchers ...
Other Medicine News:Health News:Hormone therapy may affect heart attack severity in women 2
(Date:7/22/2008)...ISBANE, Australia, July 22 /PRNewswire-FirstCall/ ... yesterday, the Board of Progen,Pharmaceuticals Li...t it,had discontinued the PI-88 phase 3 study in l...ion to develop its existing portfolio of compounds...itional compounds and,opportunities through Merger...
(Date:7/22/2008)...test awards under Therapeutics Development Initiat...tions to 23; next deadline January 20,2009, NEW ...f its mission to,speed delivery of transformative ... Michael J. Fox Foundation for Parkinson,s Researc... industry research teams. The awards,were granted ...
(Date:7/22/2008)...te-of-the-Art PET Study Confirms Tyrima Exhibits E...operties - - Results Support Initiation of P..., N.C., July 22 /- CeNeRx BioPharma,...ercializing innovative,treatments for diseases of ...to advance its lead candidate Tyrima(TM) into Phas...
(Date:7/22/2008)...UTH SAN FRANCISCO, Calif., July 22 /-...it has completed patient enrollment,in its Phase 1...lity and,ammonia scavenging effects of HPN-100 (fo...nylbutyrate) in patients with urea cycle disorders...ults in the fourth quarter,of this year., (Logo: ...
Breaking Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3GlycoMark Blood Test Included in Global Diabetes Care Guidelines as Emerging Technology 1940 1GlycoMark Blood Test Included in Global Diabetes Care Guidelines as Emerging Technology 1940 2GlycoMark Blood Test Included in Global Diabetes Care Guidelines as Emerging Technology 1940 3Highlights of Economic and Business Growth in the Tampa Bay Region 800 1Highlights of Economic and Business Growth in the Tampa Bay Region 800 2Highlights of Economic and Business Growth in the Tampa Bay Region 800 3Highlights of Economic and Business Growth in the Tampa Bay Region 800 4Poll reveals public awareness of nanotech stuck at low level 1936 1Poll reveals public awareness of nanotech stuck at low level 1936 2Poll reveals public awareness of nanotech stuck at low level 1936 3Pelosi 3A Mr President Drop the Partisan Rhetoric Put Down the Veto Pen 1933 1
... - Dynogen,Pharmaceuticals, Inc. reported positive...controlled Phase 1b trial of DDP733 for,gastroesop...ed to,demonstrate proof-of-concept for DDP733 as a...dose of DDP733 achieved,statistical significance o...n the number of reflux events and was safe and wel...
... 2007 - Gilead,Sciences, Inc. (Nasdaq:GILD) today ...al evaluating the company,s once-daily,anti-HIV dr...vir,DF) 300 mg as a potential treatment for chroni...ry efficacy endpoint. The study shows,that Viread ...ral,drug Hepsera(R) (adefovir dipivoxil) among pat...
Other Medicine Technology:Dynogen Reports Positive Results in Phase 1B GERD Study 2Dynogen Reports Positive Results in Phase 1B GERD Study 3Dynogen Reports Positive Results in Phase 1B GERD Study 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 2Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 3Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 5Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 6Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 7
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: